MEP Interest Group

The TRANSFORM MEP Interest Group is an informal group that brings together cross-party Members of the European Parliament (MEPs) who are committed to ensuring that innovative and life-changing therapies can timely reach all patients across Europe.

Why an MEP Interest Group on Transformative Therapies?

The European Parliament can play a key role in helping tackle the issues that prevent or delay access to treatments for patients by raising awareness and rethinking the current policy and legislative framework. MEPs can ensure that transformative therapies are considered as a priority in the European agenda, highlighting the potential that these novel therapies can offer to patients, resulting in better health outcomes as well as societal benefits. 

What are the main activities of the MEP Interest Group on Transformative Therapies?

The TRANSFORM MEP Interest Group hosts meetings to inform, educate and promote dialogue with decision-makers to shape the policy and legislative framework to accommodate these transformative therapies for the benefit of patients.  

Co-Chairs

(RE, Czech Republic)

Supporting Members

Claudia Gamon
Claudia Gamon
(RE, Austria)
Billy Kelleher
Billy Kelleher
(RE, Ireland)
Susana Solís Pérez
Susana Solís Pérez
(RE, Spain)
Tomislav Sokol
Tomislav Sokol
(EPP, Croatia)
Sirpa Pietikäinen
Sirpa Pietikäinen
(EPP, Finland)
Aldo Patriciello
Aldo Patriciello
(EPP, Italy)
Nicolás González Casares
Nicolás González Casares
(S&D, Spain)
Cyrus Engerer
Cyrus Engerer
(S&D, Malta)
Manuel Pizarro
Manuel Pizarro
(S&D, Portugal)
Juozas Olekas
Juozas Olekas
(S&D, Lithuania)
Tudor Ciuhodaru
Tudor Ciuhodaru
(S&D, Romania)
Pietro Fiocchi
Pietro Fiocchi
(ECR, Italy)
Emmanouil Fragkos
Emmanouil Fragkos
(ECR, Greece)
Frances Fitzgerald
Frances Fitzgerald
(EPP, Ireland)
Radka Maxová
Radka Maxová
(S&D, Czechia)
Stelios Kympouropoulos
Stelios Kympouropoulos
(EPP, Greece)
Anne Sander
Anne Sander
(EPP, France)
Tilly Metz
Tilly Metz
(Greens/EFA, Luxembourg)

Events

@TRANSFORM_CGT on Twitter Follow us →

🧬Great panel discussion at Day 2 #ECRD2022 on ensuring health systems are ready for #innovation like #ATMPs, incl best practice examples & policy ideas Future-proofing the EU for transformative therapies is core to TRANSFORM's policy asks 👉https://t.co/gtuDl2L8Be
28 June at 2:19pm
RT @ipopi_info: Today is #InternationalNeonatalScreeningDay! Stay tuned all day to hear more about what INSD is, why it was created & why #…
28 June at 11:37am
RT @eurordis: Halfway through the opening session, @yann_eurordis praises the efforts of @EU_Commission but points out that "without a cohe…
28 June at 8:57am